Scott Forsgren, of BetterHealthGuy.com, posted an excellent blog on his site regarding the Biotoxin Illness Conference hosted by Gordon Medical Associates in Santa Rosa, CA. Thank you Scott for your hard work in educating patients and doctors regarding this most important health issue.
While this blog post will not cover all of the details of the event, further information can be learned from either the recordings of this event available through Gordon Medical Associates or via several learning opportunities at SurvivingMold.com.
I continue to spend time learning more about Dr. Shoemaker’s work as I have not yet entirely addressed all of the biotoxin illness markers, especially C4a, and am interested in Dr. Shoemaker’s work as I think he’s a rare genius in the field.
The slides from this event are available here. If your doctor is not already familiar with Dr. Shoemaker’s treatment approach, ask them to get the Physician’s Approach to Biotoxin Illness DVDs or the Surviving Mold book and get educated on the protocol. The more doctors that learn how to treat biotoxin illnesses, the better off we will all be.
The biggest takeaway for me from the weekend was one that I had already known, but it is also one that I cannot reinforce enough how strongly I feel about it. In my opinion based on what I have learned from Dr. Shoemaker’s work, everyone with Lyme should have their HLA genetic testing done so that they understand if it is Lyme toxins, mold toxins, or both that they are inefficient in identifying and excreting. This information may change the course of your treatment. Additionally, if one is a mold-susceptible type, I think it is critical to have the ERMI testing done to see if your living environment is save. If one has a mold-susceptible type, an ERMI of < 2 is the goal. Anything higher than that is potentially unsafe and negatively impacting your health.
Ignoring the mold issue while treating Lyme disease is, in my opinion, much like trying to keep a boat filling up with water from sinking by using a cup to dump the water overboard when the boat itself has several holes in the bottom. You just can’t win unless we evaluate and address all of the factors involved in our ill-health. Mold is often a very critical and overlooked factor.
I’m very excited about Dr. Shoemaker’s new web site SurvivingMold.com. The information there is invaluable. I highly recommend that you spend some time on the site to better understand how to evaluate and approach biotoxin-related illness (whether it be Lyme, Mold, or other biotoxins). The Biotoxin Pathway is the best summary of Dr. Shoemaker’s work.
Here are some key points I took away from the weekend.
- 92% of people with biotoxin illness have a positive VCS test. The test can be done online at SurvivingMold.com. A negative VCS test does not rule out biotoxin illness as there can be false-negative results.
- ADH (anti-diuretic hormone) deficiency is almost universal in biotoxin illness. When MSH is low, ADH is generally low. In fact, when MSH is low, many things go wrong in the Biotoxin Pathway.
- When ADH is an issue, you lose water. Salt then gets dumped onto the skin via the sweat glands. Dr. Shoemaker did sweat chloride tests and found that when people experienced static shocks, they had high chlorides.
- “Doing air sampling is the stupidest thing I have ever heard in my life,” stated Dr. Shoemaker.
- MSH and VIP are regulatory peptides. VIP is now available as a nasal spray that can be used after you have followed all of the required steps in his treatment program. It will not work if done without having done the earlier steps. MSH is not available yet. ADH is another regulatory peptide.
- When you lose control of inflammation, inflammation goes wild. If you don’t control inflammation, it will chew you up.
- Uncontrolled inflammation can be evaluated using C4a, MMP-9, and TGF-b1 testing.
- Reduced MSH is a co-factor which can lead to MARCoNS, a nasal staph infection. MARCoNS activates inflammation. MARCoNS can also produce biofilms and biotoxins.
- TGF-b1 can be an indicator of autoimmunity. It can lead to changes in lung tissue and symptoms that are asthma-like.
- The condition that Dr. Shoemaker speaks of is not a “mitochondrial disease” but an oxygen delivery deficiency.